We analyzed a variety of clinical factors that may be associated with CRS (gender, age, transplantation, CAR-T cell dose, bone marrow tumor burden, species of CAR, costimulatory molecules, serum maximum values of IL-6 and CRP, and minimum level of CD4/CD8) separately. This evidence concerns the gene CD8A and neoplasm.